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Biosynthetic nerve grafts are desired as alternative to autologous nerve grafts in peripheral nerve
reconstruction. Artiﬁcial nerve conduits still have their limitations and are not widely accepted in the
clinical setting. Here we report an analysis of ﬁne-tuned chitosan tubes used to reconstruct 10 mm nerve
defects in the adult rat. The chitosan tubes displayed low, medium and high degrees of acetylation (DAI:
w2%, DA: w5%, DAIII: w20%) and therefore different degradability and microenvironments for the
regenerating nerve tissue. Short and long term investigations were performed demonstrating that the
chitosan tubes allowed functional and morphological nerve regeneration similar to autologous nerve
grafts. Irrespective of the DA growth factor regulation demonstrated to be the same as in controls. An-
alyses of stereological parameters as well as the immunological tissue response at the implantation site
and in the regenerated nerves, revealed that DAI and DAIII chitosan tubes displayed some limitations in
the support of axonal regeneration and a high speed of degradation accompanied with low mechanical
stability, respectively. The chitosan tubes combine several pre-requisites for a clinical acceptance and
DAII chitosan tubes have to be judged as the most supportive for peripheral nerve regeneration.
 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-ND license. 1. Introduction
In general, peripheral nerves have the ability to regenerate
following nerve lesion in contrast to the central nervous system.
However, in cases of more complex injuries with substantial loss of
nerve tissue and a subsequent defect between the nerve ends, the
requirements for axonal regeneration are not sufﬁciently fulﬁlled.
Such complex peripheral nerve injuries, which include 300,000y, Hannover Medical School,
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Ltd. Open access under CC BY-NC-ND licencases per year in Europe due to traumatic events, represent a major
cause for morbidity and disability. During the last decades
considerable efforts have been made to support and improve pe-
ripheral nerve regeneration across a nerve defect, but with limited
and minor success [1]. Therefore, despite several shortcomings and
limitations, such as misdirection of regenerating axons, neuronal
cell death, and donor site morbidity, the gold standard for bridging
a nerve defect remains grafting of an autologous nerve transplant to
overcome such large defects [2]. The purpose is to apply an
adequate substrate, including the provision of trophic and tropic
factors, for the regrowing axons in order to restore the function
after reconstruction of the nerve defect [3].
As a possible alternative for autologous nerve grafts, a variety of
materials have been tested with regard to their suitability for fabri-
cation of synthetic nerve conduits for bridging nerve defects [4]. Inse. 
Fig. 1. Illustration of the various components of the comprehensive in vivo analysis of the new chitosan tubes with different degrees of acetylation as performed by several partners
of the BIOHYBRID consortium. After the short terms of 5 and 18 days after nerve reconstruction, the connective tissue surrounding the chitosan tubes, the properties of the tubes,
tube content as well as the proximal nerve ends and corresponding dorsal root ganglia were assessed with different methods, including RT-PCR, Western Blot, histology and
immunohistochemistry. After 21 days in vivo, the newly formed regenerative matrix and the distal nerve segments were evaluated for matrix dimension, length of axonal
outgrowth, and numbers of activated and apoptotic Schwann cells and total number of DAPI stained cells in the matrix and in the distal nerve segments. In long term observation,
assessments of the motor regeneration were performed including the static sciatic index calculation, non-invasive and invasive electrodiagnostical measurements and muscle
weight evaluation. Histological analyses were performed with the connective tissue and the regenerated nerve tissue. Finally, distal nerve morphometry and detailed analyses of the
tube properties after nerve reconstruction and explantation were performed.
K. Haastert-Talini et al. / Biomaterials 34 (2013) 9886e9904 9887addition to non-degradable silicone tubes, which were earlier used
clinically as an alternative for nerve repair [5,6] several biodegrad-
able materials have been developed in animal experiments and
applied for clinical investigation of nerve reconstruction devices
[1,4]. Conduits, which are approved by the Food and DrugAdministration (FDA) and authorized by the EC respectively, include
Neurotube poly(glycolide) (PGA) tubes (successfully used in the
clinical repair of digital nerves with defects of up to 3 cm in length
[7]), Neura-Gen collagen nerve tubes [8,9], and Neurolac tubes
[10,11]. Furthermore, processed, i.e. extracted, nerve allografts have
K. Haastert-Talini et al. / Biomaterials 34 (2013) 9886e99049888also been approved and applied to reconstruct nerve defects [12].
Although these off-the-shelve products have unlimited supply and
avoid donor site morbidity, they have serious limitations in sup-
porting peripheral nerve regeneration. Functional outcome after
their use for nerve reconstruction is highly variable and only com-
parable to autologous nerve grafting when short defects in small
diameternervesare tobe reconstructed [2,13].Until today,notubular
or other type of biosynthetic nerve graft has shown strong potential
to replace autologous nerve grafting for reconstruction of the sub-
stantial humannerves, such as themedianorulnarnerve trunks [14].
During the last years, the natural biopolymer chitosan e a de-
rivative of chitine has gained increasing interest in biomedical and
tissue engineering applications. Chitosan displays biocompatibility,
biodegradability, low toxicity, and structural similarity to natural
glycosaminoglycans. Recent in vitro studies revealed the suitability
of chitosan membranes as substrate for survival and oriented
Schwann cell growth [12] as well as survival and differentiation of
neuronal cells [15,16]. In addition, chitosan tubes alone or in
combination with other biomaterials can efﬁciently bridge pe-
ripheral nerve defects [4,17]. However, improved technologies have
been developed to overcome the poor mechanical strength of chi-
tosan tubes, which was one of the main factors limiting the use of
such tubes as nerve guidance channels for clinical applications until
now [18]. Moreover, optimal biodegradation and cell compatibility,
which are important features for tissue engineering, had to be
adjusted by different degrees of acetylation of the chitosan [15].
The aim of the present study was to conduct in a multidisci-
plinary approach a comprehensive evaluation of chitosan tubes
displaying different degrees of acetylation. The chitosan tubes were
used to bridge a 10mmdefect in rat sciatic nerves. In addition to the
ﬁne-tunedmanufacturing of the chitosan tubes and their evaluation
with regard to biocompatibility, short and long term in vivo studies
were performed and a battery of parameterswere analysed. Thereby
not only focussing on the effects on morphological and functional
peripheral nerve regeneration, but also validating putative side ef-
fects, like Schwann cell survival and expression of transcription
factors, neurotrophic factor regulation as well as immunological
reaction. Finally, the properties of the non-implanted chitosan tubes
were compared in structural and chemical analyses to tubes after
explantation from the nerve reconstruction site.
2. Materials and methods
2.1. Manufacturing of chitosan
Medical grade chitosan supplied by Altakitin S.A. (Lisbon, Portugal) with a
molecular weight (MW) of 260 kDa and degree of acetylation (DA) of 90% was ob-
tained from Pandalus borealis shrimp shells using standard conditions for chitin
extraction and deacetylation, following ISO 13485 requirements and speciﬁcations.
The puriﬁcation method consisted in homogeneous washing (liquid/liquid extrac-
tion) of chitosanwith EDTA and SDS for heavy metals and protein removal. After the
extractions, the product was washed with deionized water and neutralized prior to
lyophilisation. The product was analysed using several methods and techniques to
attest compliance with internal standards for degree of acetylation, molecular
weight, heavy metal content, protein content, endotoxins, bioburden, pH, ash con-
tent and apparent viscosity.
2.2. Determination of the degree of acetylation by nuclear magnetic resonance
(NMR) spectroscopy
The samples (approx. 5 mg) were dissolved in 2% DCl in D2O (v/v, Sigmae
Aldrich, Germany). The ﬁd signal was acquired at 70 C and suppressing the solvent
signal (pulse program zgpr). Analysis and integrations were performed in MestRe-
Nova software according to Ref. [19].
2.3. Analysis of the molecular weight by gel permeation chromatography (GPC)
The samples (approx. 5 mg) were dissolved in 1 ml of eluent (AcOH/AcONa
buffer pH 4.5, Panreac, Spain) and ﬁltered through a 0.45 microns ﬁlter prior to
injection (100 ml). The chromatographs were obtained at room temperature with aﬂow rate of 1 ml/min. A Varian PL aquagel-OH MIXED bed column (Varian, France)
was used and a refractive index detector. Previously a calibration curvewas obtained
by using Varian pullulan polysaccharides certiﬁed standards in the same chro-
matographic conditions.
2.4. Production of chitosan tubes
Chitosan tubes were manufactured by Medovent GmbH (Mainz, Germany) un-
der ISO 13485 conditions from chitin tubes made by a proprietary extrusion process,
followed by distinctive washing and hydrolysis steps to adjust the required low,
medium and high degree of acetylation (DA). Chitosan tubes have therefore been
classiﬁed into DAI tubes (low DA, w2%), DAII tubes (medium DA, w5%) and DAIII
tubes (high DA, w20%). Tubes were ﬁnally cut into the required lengths and steril-
ized by electron beam.
2.5. In vitro cytotoxicity tests
In order to assess the short term cytotoxicity of the developed chitosan tubes,
both the Minimum essential medium (MEM) extraction and the MTS cell viability
tests were performed with 24 h, 72 h, and 7 days of extraction period following the
guidelines described before [20]. In all tests the ratio material weight to extraction
ﬂuid was constant and equal to 0.2 g/ml for chitosan tubes (DAI: w2%, DAII: w5%,
DAIII:w20%), while for latex (negative control for cell viability) the ratio of material
outer surface to extraction ﬂuid was 2.5 cm2/ml. After each period the extracts were
ﬁltered through a 0.45 mm pore size ﬁlter. These assays are particularly suitable for
assessing the possible toxic effect of leachables extracted from biomedical polymers.
With the MEM extraction test changes in cell morphology and growth inhibition are
evaluated, whereas the metabolic cell viability is determined with the MTS test. In
both cases, latex extracts (same extraction periods) were used as negative controls,
while standard culture medium was used as positive control for cell death.
2.5.1. Cell culture
For the present experiment P1 rat bone marrow Mesenchymal Stromal Cells
(RBMSCs) were used, which had been isolated according to the protocol described
earlier [21]. Upon isolation cells were expanded in alpha-MEM (Gibco, USA), sup-
plemented with 10% foetal bovine serum (FBS, Biochrome, Portugal) and 1% of an
antibioticeantimycotic mixture (Gibco). For the MTS test (n ¼ 5, 2  104 cells/well)
and theMEM extraction (n¼ 3, 2104 cells), RBMSCswere seeded in a 24 well plate
for 72 h at 37 C, in a 5% (v/v) CO2 cell culture incubator, prior to extract incubation.
2.5.2. MTS test
72 h after cell seeding, culture medium was removed from the wells and an
identical volume (500 ml) of extraction ﬂuid was added. Cultures were then incu-
bated with the extracts for 72 h after which their metabolic viability was assessed
through the MTS test. This is based on the bioreduction of [3-(4,5-dimethylthiazol-
2-yl)-5-(3carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] (MTS, Prom-
ega, USA), into a brown formazan product by dehydrogenase enzymes. After ex-
tracts, positive and negative controls were removed, a mixture of DMEM with MTS
(5:1 ratio) was added to each well. Cells were then incubated for 3 h at 37 C in a 5%
CO2 cell culture incubator after which the O.D. was determined at 490 nm using a 96
well plate reader (Tecan Sunrise, Männedorf, Switzerland).
2.5.3. MEM extraction test
72 h after cell seeding, culture medium was removed from the wells and an
identical volume (500 ml) of extraction ﬂuid was added. Cultures were then incu-
bated with the extracts for 72 h after which a live/death assay by staining live cells
with calcein-AM and non-viable cells with propidium iodide was performed. Cul-
tures were observed in ﬂuorescence microscopy.
2.6. Experimental design
In order to comprehensively analyse the performance of the newly designed
chitosan tubes of different DA in vivo, short term and long term observation periods
were chosen. As illustrated in Fig. 1, nerve reconstruction with chitosan tubes was
performed and samples were collected formolecular and histological analysis after 5
and 18 days. The initially formed regenerative matrix was analysed 21 days after
nerve reconstruction with chitosan tubes (short term). During the long term
observation over 3 months the progress of sciatic nerve regeneration was periodi-
cally monitored with several functional tests. Finally, a comprehensive histo-
morphometrical analysis of the regenerated nerve tissue and further evaluation of
the macroscopic and chemical tube properties were performed.
2.7. Animals and surgical procedure
The in vivo studies were performed in two different laboratories [Dahlin lab at
Lund University (ULUND), Sweden, and Grothe lab at Hannover Medical School
(MHH), Germany] with different animal breeders and regimes for anaesthesia and
analgesia due to different local animal protection rules. All animal experiments were
approved by the local animal protection committees (animal ethics committee in
Fig. 2. Illustration of connective analysis. (A) Macroscopically three categories of optical density of the expanded connective tissue could be deﬁned. (B) The area of sample
connective tissue was determined in haematoxylineeosin stained 7 mm parafﬁn cross sections. In these sections the inner surfaces of the connective tissue (contact area with
chitosan tubes) are facing each other. (C) Within the contact area with the chitosan tubes the number of multinucleated giant cells (detail) was determined. Furthermore the
thickness of sample connective tissue was evaluated at 5 randomly chosen locations.
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common, female Wistar rats (225e250 g) were applied to the experiments and
housed in groups of four animals under standard conditions (room temperature
22  2 C; humidity 55  5%; lightedark-cycle 14-h/10-h [MHH] or 12-h/12-h
[ULUND]) with food and water ad libitum.
For surgery, animals were anesthetized, sufﬁcient analgesia induced and placed
on a thermostatic blanket, to keep the body temperature stable, on the right side for
surgery on the left sciatic nerves. After shaving the left hind leg the skin was dis-
infected, and aseptic techniques were used to ensure sterility. A skin incision was
made with a surgical blade along the femur, and the gluteus and biceps femoris
muscles were separated by sharp and blunt dissection to expose the sciatic nerve.
Thewoundwas kept openwith the aid of small retractors. The sciatic nerve, exposed
at the midthigh level, was transected with a single microscissors cut at a constant
point (6 mm from the exit of the gluteus muscle). For tube transplantation 5 mm of
the distal sciatic nerve endwere removed and 14mm long tubes were used to bridge
a 10 mmnerve defect. Preparation of the tubes before nerve reconstruction included
four washing steps in NaCl (4  30 min) as well as an overnight washing step. Four
different observation periods were chosen after which the animals were ﬁnally
examined and sacriﬁced prior to explantation of the implants and regenerated tis-
sue: as short term periods 5 days (DAI, DAII, DAIII, n ¼ 6 animals in each group), 18
days (DAI, DAII, DAIII, n ¼ 6 animals in each group) and 21 days (DAI n ¼ 10, DAII
n ¼ 10, DAIII n ¼ 9); as long term period 3 months (13 weeks; DAI, DAII, DAIII, n ¼ 17
animals in each group). Control animals for the long term investigations (n ¼ 17)
received an autologous nerve graft of 10 mm length, which was reversed (distale
proximal) and ﬂipped 90 before three sutures (9-0, Ethilon) were placed 120 apart
from each other. In control animals for the 5 days (n ¼ 4) and 18 days (n ¼ 4) shortterm investigations, the nerve defect was not reconstructed, but the proximal and
distal nerve ends were folded over and sutured to themselves after removal of the
5 mm piece.
Anaesthesia at MHH was induced by chloral hydrate (370 mg/kg body weight,
i.p., SigmaeAldrich, Germany, MHH) combined with analgesia by buprenorphine
(0.045 mg/kg body weight, Buprenovet, Germany). Anaesthesia at ULUND was
induced by intraperitoneal injection of a mixture of Rompun (20 mg/ml; Bayer
Health Care, Germany) and Ketalar (10 mg/ml, Pﬁzer, Finland). Postoperatively, all
rats were treated with Temgesic (0.3 mg/ml; Schering-Plough Europe, Belgium) to
prevent pain.
2.8. Quantitative RT-PCR
The ipsi- and contralateral dorsal root ganglia (DRGs) L3eL5 of animals sub-
jected to the 5 and 18 days observation period were dissected and snap frozen in
liquid nitrogen (5 days: DAI, DAII, DAIII n¼ 3 each, control n¼ 4; 18 days: DAIþDAIII
n ¼ 3 each, DAII þ control n ¼ 4 each). Tissue samples of each animal were ho-
mogenized and total RNA was extracted according to the manufacturer’s in-
structions (RNeasy Plus Micro Kit, Qiagen, Germany). The eluate of 14 ml was used
completely for cDNA synthesis using the iScript Kit (BioRad, Germany). Primer se-
quences were as previously stated for brain-derived neurotrophic factor (BDNF),
growth-associated protein-43 (GAP-43) [22] and nerve growth factor (NGF) [23].
Further primer sequences were as follows: ﬁbroblast growth factor-2 (FGF-2)-F: 50-
GAACCGGTACCTGGCTATGA-30; FGF-2-R: 50-CCAGGCGTTCAAAGAAGAAA-30; inter-
leukin 6 (IL6)-F: 50-CGTTTCTACCTGGAGTTTGTGAAG-30; IL6-R: 50-GGAAGTTGGGG-
TAGGAAGGAC-30; tyrosine kinase receptor B (TrkB)-F: 50-CCCAATTGTGGTCTGCCG-
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serial cDNA dilutions and estimated to be 100%. Quantitative RT-PCR was performed
with Power SYBR-Green PCR Master Mix (Applied Biosystems) on a StepOnePlus
instrument (Applied Biosystems, Darmstadt, Germany) as described before [24].
Fold changes in mRNA levels are stated in comparison to the levels measured at the
respective day on the contralateral side of the control animals. Calculationwas done
by using the 2(DDCt) method and normalized to the housekeeping gene pepti-
dylprolyl isomerase A (Ppia)-F [24].
2.8.1. Western Blot
Tube contents were collected 5 and 18 days after nerve reconstruction with
chitosan tubes and each pooled from 5 to 6 animals per DA. Samples were ho-
mogenized in 40 ml Radioimmunoprecipitation assay (RIPA) buffer (according to Ref.
[25]). Samples were then boiled in Laemmli buffer (5 min) and separated by sodium
dodecyl sulphate (SDS) polyacrylamide gel electrophoresis (PAGE) (12% gel) before
being transferred (50 mg) electrophoretically to nitrocellulose membranes (Hybond
ECL, Amersham) with 4 ng recombinant BDNF serving as positive control. Mem-
branes were then probed with anti-BDNF (sc-546, 1:1000, rabbit, Santa Cruz, Ger-
many) and anti-NGF (ab6199, 1:2000, abcam, UK) antibody and analysed following
Ref. [25].
2.9. Assessment of the connective tissue
The connective tissue surrounding the tubes was macroscopically and histo-
logically analysed. For the macroscopic evaluation, the connective tissue was
dissected, spread on a scale paper glass plate and photographs taken of every
sample. From the photographs, three classes of macroscopic connective tissue op-
tical density were deﬁned as translucent, translucenteopaque and opaque (Fig. 2A).
Afterwards samples of the connective tissue (n ¼ 4e6 per DA and evaluation time
point), were folded and sutured at the proximal end such that the chitosan tubes
contact surfaces were facing each other (Figs. 1 and 2B and C). The tissue was then
ﬁxed overnight in 4% paraformaldehyde (PFA) and parafﬁn embedded. For histo-
logical analysis blind-coded 7 mm parafﬁn sections were cut from the distal end of
the connective tissue and subjected to haematoxylineeosin (HE)-staining or
immunohistochemistry for activated macrophages (see below) in the same sections.
In 4e6 HE-stained sections per sample covering a distaleproximal distance of
approximately 200 mm, the connective tissue area (Fig. 2B) and thickness (at 5
randomly chosen points, Fig. 2C) was determined. Furthermore, the number of
multinucleated giant cells per mm2 of the contact area with the chitosan tubes was
manually quantiﬁed (Fig. 2C). Light microscopic evaluation (Olympus BX53 and
Olympus BX51, Denmark) was aided by the programmes cellSense Dimensions and
cellSense Entry (both Olympus; Denmark).
Immunohistochemistry was performed to estimate the number of ED1-stained
cells, i.e. activated macrophages (n ¼ 4e5/group). Therefore, two blind-coded 7 mm
parafﬁn cross sections approximately 140 mm apart from each other were incubated
in PBS þ 5% rabbit serum as a blocking step prior to incubation with primary mouse
anti-ED-1 antibody (1:1000; MCA 275R Serotec, UK) at 4 C overnight. The next day
sections were washed with PBS (3) before being incubated with Alexa 555-
conjugated secondary goat-anti-mouse antibody (1:1000; A21422, Invitrogen, Ger-
many) for 1 h at room temperature (RT). Sections were ﬁnally counterstained with
the nuclear dye 40 ,60-diamino-2-phenylindole (DAPI, 1:2000, Sigma, Germany) in
PBS for 2 min at room temperature and then mounted with Moviol (Calbiochem,
Germany, N 475904). Two photomicrographs were each taken from an area with
minimal and maximal ED1 signal per section (20 magniﬁcation) using an IX70
microscope (Olympus) and the cellP software (Olympus, Denmark) (Olympus). The
number of ED1-þ cells was counted as number/mm2 with the help of the ImageJ
software (NIH, USA). The nuclear DAPI counterstaining was used to clearly identify
ED1-immunopositive cells but not for further quantiﬁcation in this case.
2.10. Analysis of regenerated matrix within the chitosan tubes at 21 days after nerve
reconstruction
The sciatic nerve together with the chitosan tube and its content was harvested
21 days after surgery. The chitosan tube was removed, there after the tube content
with proximal and distal nerve segments were ﬁxed in Stefanini solution (4%
paraformaldehyde and 1.9% picric acid in 0.1 M phosphate buffer pH 7.2) for 24 h. The
samples were then washed in 0.01 M PBS pH 7.4 three times and stored in 20% su-
crose solution overnight for cryoprotection. Before sectioning using a cryostat, the
samples were embedded in OCT Compound (Tissue-Tek, Histolab products AB,
Gothenburg, Sweden) and frozen. The nerves sectioned longitudinally at 6 mm
thickness were collected on Super Frost plus glass slides (Menzel-Gläser,
Germany).
2.10.1. Immunohistochemistry
Immunohistochemistry was performed for neuroﬁlaments, activating tran-
scription factor 3 (ATF3), and cleaved caspase 3 to evaluate axons, activated Schwann
cells, and apoptotic Schwann cells, respectively, as described [26,27]. In short, the
sections were washed in PBS for 5 min and incubated overnight at 4 C with anti-
human neuroﬁlament protein (DAKO Glostrup, Denmark), diluted 1:80 in 0.25%Triton-X 100 and 0.25% BSA in PBS. The next day the slides were washed with PBS
3  5 min, then incubated for 1 h at room temperature with the secondary antibody
ALEXA Fluor 594 conjugated goat anti-mouse IgG (Invitrogen, Molecular Probes,
USA), diluted in 1:500 in PBS and coverslipped.
For ATF-3 immunohistochemistry, the sections were washed for 5 min in PBS
and then incubated with rabbit anti-ATF-3 polyclonal antibody (1:200; Santa Cruz
Biotechnology, USA), diluted 1:200 in 0.25% Triton-X 100 and 0.25% BSA in PBS, or
with anti-cleaved caspase-3 antibody (1:200; Invitro Sweden AB, Stockholm, Swe-
den); both diluted in 0.25% Triton-X 100 and 0.25% BSA in PBS) overnight at 4 C. The
next day the slides were washed in PBS 3  5 min and then incubated with the
secondary antibody Alexa Fluor 488 conjugated goat anti-rabbit IgG (Invitrogen,
Molecular Probes, USA), diluted in 1:500 in PBS for 1 h at room temperature. Finally,
the slides were washed 3  5 min in PBS, mounted with 40 ,60-diamino-2-
phenylindole DAPI (Vectashield, Vector Laboratories, Inc. Burlingame, USA) to
visualize the oval shaped nuclei (i.e. for counting the total number of the cells) and
then mounted and coverslipped.
The blind-coded sections were photomicrographed using a ﬂuorescence mi-
croscope (Eclipse, Nikon, Tokyo, Japan) provided with a digital system camera
(Nikon 80i) connected to a computer and the length of the outgrowing axons was
measured from the site of lesion into the formed matrix in three randomly selected
sections. The stained cells for cleaved caspase-3 and ATF-3 were also counted in one
section (image size 500  400 mm) in the matrix 3 mm from the proximal nerve end
(Fig. 1) and in the distal nerve segment as described [28]. The same squares were
also used for counting the total number of DAPI stained cells. The images (20
magniﬁcation) were analysed with NIS elements (Nikon, Japan). Double staining for
cleaved caspase 3 and S-100 was performed as described [27].
2.11. Functional evaluation
During the long term observation period of 3 months (13 weeks) after nerve
reconstruction, the progress of functional motor recovery was monitored by
calculation of the Static sciatic index, electrophysiological measurements (serial
non-invasively and ﬁnal invasively) and calculation of the lower limb muscle weight
ratio. The investigators were blinded to the conditions of sciatic nerve reconstruc-
tion applied to the animals.
2.11.1. Static sciatic index (SSI)
The healthy SSI was determined 1 week prior to surgery and after surgery in
weeks 1, 4, 9 and 12 as described before [29]. In brief, webcam images of the toe
spreading of the right (contralateral) and left (ipsilateral) paw were acquired from
the rats placed inside a plastic box located on a glass table. Using a freely available
image-editing program (AxioVision, Zeiss, Jena, Germany), the distance between toe
1 and 5 (toe spread TS) as well as 2 and 4 (intermediate toe spread ITS) was
measured for the lesioned (LTS; LITS) and non-lesioned (NTS; NITS) hind paws. The
SSI was then calculated using the following equations (TSF ¼ toe spread factor;
ITSF¼ intermediate toe spread factor): TSF¼ (LTS NTS)/NTS; ITSF¼ (LITS NITS)/
NITS; SSI ¼ (108.44 * TSF) þ (31.85 * ITSF)  5.49.
2.11.2. Serial non-invasive electrodiagnostic recordings
For evaluation of ongoing muscle reinnervation in weeks 4, 9 and 12 after sur-
gery a portable electrodiagnostic device (Keypoint Portable; Medtronic Functional
Diagnostics A/S, Denmark) was used. Therefore, animals were anesthetized as
described above and placed in a prone position and ﬁxed with tape with the hin-
dlimbs extended on a metal plate on top of a thermostatic blanket. Only during
recordings the thermostatic blanket was turned off to avoid interfering signals. The
sciatic nerve was stimulated with single electrical pulses (100 ms duration and
supramaximal intensity) delivered by monopolar needles (30G, diameter 0.3 mm,
length 10 mm; Alpine BioMed, Denmark) percutaneously placed either at the sciatic
notch, proximal to the injury (proximal stimulation, cathode directly at sciatic notch,
anode 1 cm more proximal) or in the popliteal fossa (distal stimulation). The com-
pound muscle action potentials (CMAPs) of the tibialis anterior (TA) and plantar (PL)
muscles were recorded by means of another pair of monopolar needles inserted
across the skin on the muscle belly. To ensure reproducibility the recording needles
were placedwith the help of anatomical landmarks to secure the same placement on
all animals. The active recording electrode is placed subcutaneously at the ﬁrst third
of the distance between knee and ankle on the TA muscle, and at the third meta-
tarsal space for PL muscle recordings. The reference needle electrodewas inserted at
the distal phalange of the second or fourth toe. A ground needle electrode was
inserted in the skin at the knee.
Taking into account the latency difference of the two stimulation points and the
distance between them, the electrodiagnostic device calculated automatically the
nerve conduction velocity (NCV). Furthermore, the signals amplitude and the area
under the curve (AUC) of the negative CMAP peaks were recorded. Control values
were obtained from the non-lesioned, right hindlimb.
2.11.3. Final invasive electrodiagnostic recordings
On the last day of observation (week 13) animals were once more anesthetized
and the sciatic nerves were exposed consecutively on the lesioned and non-lesioned
side. The recording electrodes were placed as described above. Using a bipolar steel
Fig. 3. (A) Metabolic activity of RBMSCs incubated with extracts from the chitosan tubes of different degrees of acetylation (DAI ¼w2%; DAII ¼w5%; DAIII ¼w20%) for 72 h (MTS
assay). No negative effect on the metabolic viability by any DA could be detected in comparison to the positive control. (B) Representative photomicrographs from the MEM
extraction test. Incubation with the extracts from DAI-, DAII-, or DAIII-chitosan tubes did not negatively inﬂuence the cell density of cultured RBMSCs.
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K. Haastert-Talini et al. / Biomaterials 34 (2013) 9886e99049892hook electrode the sciatic nerves were directly stimulated proximal and distal to the
transplants [29]. Single electrical pulses (100 ms duration) with gradually increased
intensity (not exceeding 8 mA) were applied in order to evaluate the threshold and
maximal CMAP. Furthermore, the NCV was calculated by stimulating the sciatic
nerve proximal and distal with a current intensity of 1 mA.
2.11.4. Muscle weight ratio
After completing the experiments the animals were sacriﬁced, the transplants
with the adjacent nerve tissue were dissected and the gastrocnemius muscle and TA
muscle of both hindlimbs were excised and weighted in order to determine the
muscle weight ratio ([g]ipsilateral/[g]contralateral).
2.12. Histo-morphometrical assessment of the regenerated nerve tissue
The transplants with the adjacent nerve tissue were harvested and the regen-
erated nerve tissue extracted from the chitosan tubes. The regenerated nerve tissue
was separated into a proximal and a distal part by a cut at 1 mm distal to the distal
suture site (Fig. 1).
Five mm of the distal segment were then prepared for the stereological analysis
(Fig. 1) by transferring the tissue into a ﬁxative according to Karnovsky (2% PFA and
2.5% glutaraldehyde in 0.2 M sodium cacodylate buffer, pH 7.3) for 24 h, then rinsed
three times with 0.1 M sodium cacodylate buffer containing 7.5% sucrose, prior to
post-ﬁxation in 1% OsO4 for 2 h. Dehydrationwas performed in an ethyl alcohol row
(5 5min 25%, 5 5min 50%, 5 5min 75%). The samples were then shipped to the
partner laboratory at the University in Turin for embedding in a mixture of Araldite
resin (Sigma) following Glauerts’ procedure [30].
The proximal regenerated nerve tissue was subjected to ﬁxation in 4% PFA
overnight at 4 C. Afterwards Parafﬁn-embedding was performed in a Citadel tissue-
embedding-automatic unit (Shandon Citadel 2000; USA) to prepare the tissue for
HE-staining and immunohistochemical analysis.
2.12.1. Stereology/nerve morphometry
From each specimen of the distal nerve, 2.5 mm thick series of semi-thin
transverse sections were cut using an Ultracut UCT ultramicrotome (Leica Micro-
systems, Germany). Finally, sections were stained using Toluidine blue and analysed
with a DM4000B microscope equipped with a DFC320 digital camera and an IM50
image manager system (Leica Microsystems, Germany). Systematic random sam-
pling and D-dissector were adopted, using a protocol previously described [31] in
order to evaluate the total ﬁbre number, ﬁbre and axon diameter, myelin thickness
and g-ratio.
2.12.2. Histology
Serial 7 mm-cross sections were obtained from the distal end of the regenerated
nerve tissue and cut in proximal direction over a distance of approximately 1000 mm.
Blind-coded sample sections (from n¼ 5 randomly chosen animals per group) taken
from the distal end and 320 mm more proximal were processed in HE-staining in
order to examine the number of multinucleated giant cells per mm2 in the centre
area as well as in the perineurium. Sections were examined in light microscopy
(Olympus BX53; Denmark) software-aided with cellSense Dimensions (Olympus;
Denmark). Overview photomicrographs were used for the measurements.
Additional blind-coded sample sections (from n ¼ 8 randomly chosen animals
per group) taken at deﬁned distances in distaleproximal direction (0 mm (¼1 mm in
distal stump), 64 mm, 128 mm, 320 mm, 384 mm, 448 mm, 672 mm, 736 mm, 992 mm,
1056 mm (¼distal end of former nerve defect)) were subjected to double-
immunohistochemistry for activated macrophages (ED-1) and neuroﬁlaments (NF-
200). Blocking and ED-1-immunohistochemistry were performed as described
above. After incubation with the secondary antibody the sections were further
washed with PBS (3) and a second blocking step with 0.5 M trisaline buffer (60.6 g
tris þ 9 g NaCl in 1.l H2O; pH 7.4) containing 3% milk powder and 0.5% triton X-100
followed by overnight incubation (4 C) with primary rabbit anti-NF-200 antibody
(1:200; N4142, Sigma, Germany). After washing with trisaline buffer (3), incuba-
tion with Alexa 488-conjugated secondary goat-anti rabbit antibody (1:1000,
A11034, Invitrogen, Germany) was performed for 1 h at RT. Sections were ﬁnally
counterstained with DAPI and mounted with Moviol. The nuclear DAPI counter-
staining was used to clearly identify ED1-immunopositive cells but not for further
quantiﬁcation in this case.
For quantiﬁcation of the number of activated ED1-immunopositive macro-
phages/mm2, seven photomicrographs per section were randomly taken (20
magniﬁcation) in the outer area (4 photomicrographs) and in the centre area (3
photomicrographs) to examine approximately 32% of the complete section area.
Finally, the thickness of the perineurium was evaluated on theses sections as well,
therefore at three randomly chosen locations the thickness was determined and the
mean calculated for each sample.
2.13. Analysis of tube properties after explantation
On day 5 and day 18 after nerve reconstruction the chitosan tubes were
explanted. On day 18 a surrounding connective tissue could be dissected, macro-
scopically classiﬁed and processed for histological analysis. On day 5 and day 18 thetubes and their contents were stored for Western Blot analysis of the content.
Therefore the middle parts of the tubes were harvested by cutting of the proximal
and distal ends of the tubes at the suture sites. Also upon explantation in week 13
after nerve reconstruction (long term observation, 3 months), the tubes were
explanted, dissected from surrounding connective tissue and stored in 0.9% NaCl
solution for further analysis of biomaterial properties.
The properties of the tubes, the connective tissue as well as the macroscopic
nerve cable peculiarities were then classiﬁed and connective tissue samples were
processed for histological evaluation. Furthermore, tube samples (before and after
nerve reconstruction) were analysed by Scanning electron microscopic (SEM) or
biochemical tests (n ¼ 3/group).
2.14. Statistics
In the different laboratories contributing to the presented study different sta-
tistical software was used, either the statistical package SPSS (version 17.0 or 20.0,
IBM, USA) or GraphPad InStat software, version 5.0.3.0 & 6.00 for windows
(Graphpad Software, CA, USA). A p value of <0.05 was taken as statistically signiﬁ-
cant. The statistical tests used for the different cytotoxical, functional and histo-
logical evaluations are stated in the respective results sections. For nerve stereology,
the statistical analysis was performed using two or one-way ANOVA. If this analysis
identiﬁed a signiﬁcant difference the post-hoc HSD Tukey’s test, or Bonferroni were
applied for paired comparisons. KruskaleWallis, with subsequent ManneWhitney
as post-hoc, was used to detect differences between groups. Furthermore, the
proportion of animals per group that displayed a predeﬁned qualitative parameter
(evocable CMAP) was calculated as percentage (0e100%) and analysed with the Chi-
Square-test.
3. Results
3.1. In vitro cytotoxicity assays
In vitro cytotoxicity assays were performed to test the
biocompatibility of the new chitosan tubes and the inﬂuence of the
different degrees of acetylation (DA) on it. The MTS test revealed
that the leachables and degradation products released by the chi-
tosan tubes of different DA (i.e. DAI, DAII, DAIII) did not negatively
affect the metabolic viability of RBMSCs when compared to the
positive control (Fig. 3A). Similarly, the MEM extraction test
revealed no negative inﬂuences on the cell densities (Fig. 3B).
Therefore, the tested samples can be considered as non-cytotoxic,
as the leachables and degradation products released by chitosan
tubes tested with different DA did not induce any deleterious ef-
fects on RBMSCs.
3.2. In vivo evaluation after nerve reconstruction with chitosan
tubes
Chitosan tubes of DAI, DAII, DAIII were implanted to bridge a
10 mm defect of lesioned sciatic nerves and compared with con-
trols 5, 18, 21 days, and 3 months, respectively, after nerve recon-
struction (Fig. 1).
3.2.1. Short term observation (5, 18 days)
Five and 18 days after nerve lesion and nerve reconstruction
with chitosan tubes of different DAs, qRT-PCR for neurotrophic
factors (NGF, FGF-2, BDNF), the cytokine IL-6, the BDNF-receptor
TrkB and for GAP-43 were performed on DRGs (L3eL5). All data
were normalized to the contralateral non-lesioned site of control
animals in which the separated ipsilateral nerve ends were folded
over and sutured to themselves. In accordance with the expression
pattern in the DRGs of the control group, NGF, FGF-2, IL-6, BDNF
and GAP-43 were up-regulated (p  0.05, t-test) as well in the
presence of the tubes, whereas TrkB remained unchanged in all
experimental groups (Fig. 4A). In addition, therewere no signiﬁcant
changes in the expression patterns of the respective neurotrophic
factors between 5 and 18 days. It can be concluded that chitosan
tubes do not inﬂuence the physiological up-regulation of neuro-
trophic factors following nerve injury.
Fig. 4. (A) Regulation of mRNA levels of representative neurotrophic factors and regeneration associated proteins at the lesioned site, 5 and 18 days after nerve reconstruction with
chitosan tubes or control surgery. Values were normalized to the non-lesioned site of the control group, DAI, DAII, DAIII, n ¼ 3 each; control, n ¼ 4. A representative Western Blot of
pooled tube content (n ¼ 5e6/group) is shown for BDNF (B). DAI ¼ w2%; DAII ¼ w5%; DAIII ¼ w20%.
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Fig. 5. Connective tissue developed around the chitosan tubes of different degree of acetylation was analysed for (A) its optical density and (B) its area [mm2] as well as for (C) the
number of multinucleated giant cells within the contact area to the chitosan tubes and (D) the number of activated macrophages (ED-1-immunopositive, ED1-þ cells). Signiﬁcant
changes were detectable between the short and the long term evaluation, but not among the connective tissue surrounding chitosan tubes of different degree of acetylation
(DAI ¼w2%; DAII ¼w5%; DAIII ¼ w20%). Statistical tests used: (A) Chi-Square-test, asterix indicating differences between DAIII-tubes and others, p < 0.05; (C) Two way ANOVA,
Tuckey’s multiple comparison, asterix indicating difference to 18 days, p < 0.001.
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tube content in order to detect the relative amounts of BDNF and
NGF secreted into the chitosan tubes. Both, 5 and 18 days after
nerve reconstruction pre-mature and mature BDNF and NGF (data
not shown) were detectable in the pooled tube content with no
difference between the DAs (Fig. 4B).
3.2.1.1. Connective tissue evaluation. Five days after nerve recon-
struction with the chitosan tubes no surrounding connective tissue
was detectable. At 18 days after nerve reconstruction, macroscopic
evaluation revealed a signiﬁcant shift to a higher optical tissue
density for DAIII tubes (Fig. 5A). However, measurements of the
connective tissue area (Fig. 5B) and thickness (data not shown) did
not reveal any signiﬁcant differences. The connective tissue contact
areawith the implanted tubes was further examined on HE-stainedsections with regard to the presence of multinucleated giant cells
and on ED1-immunopositive/DAPI counterstained sections with
regard to activatedmacrophages, respectively. The quantiﬁcation of
giant cells, which are typically found in the environment of foreign
materials, revealed no differences among the connective tissue in
contact with DAI, DAII or DAIII chitosan tubes (Fig. 5C). Also the
number of activated macrophages (ED1-immunopositive cells) was
not altered among the different DAs (Fig. 5D).
3.2.2. Nerve regeneration, activation and apoptosis in short term
(21 days)
3.2.2.1. The formed matrix. A matrix was formed in the chitosan
tubes at 21 days. In separate experiments (results not shown), the
content of the tube was examined at 10, 14 and 18 days, but there
was not a sufﬁcient and bridging matrix formed at these time
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measured at three different sites (Fig. 6A; Table 1), and showed a
somewhat hourglass shape, and with no statistical differences be-
tween the three types of acetylation tubes at any of the measured
sites (Table 1).
3.2.2.2. Axonal outgrowth and Schwann cells. The immunohisto-
chemical evaluation revealed a length of axonal outgrowth of about
7.9e8.6 mm in the three acetylation variants with no statistical
difference present (KruskaleWallis p ¼ 0.28), but with a tendency
to shorter growth in the DAIII-tube group. S-100 staining revealed
that Schwann cells were present in the matrix along the entire tube
(Fig. 6B).
3.2.2.3. ATF3 stained Schwann cells. Few ATF3 stained cells were
present in the matrix, but without any signiﬁcant difference
(Table 1) in the tubes, although DAPI stained cells were seen.
However, a considerable number of ATF3 stained cells, with a sig-
niﬁcant difference between the three DAs (i.e. lowest in DAI- and
highest in DAIII-tubes), was present in the distal nerve segment at
21 days (Table 1).
3.2.2.4. Cleaved caspase 3 stained Schwann cells. In contrast to ATF3
staining, cleaved caspase 3 stained cells were observed in the ma-
trix along the entire length of the matrix in all three types of the
chitosan tubes (Table 1, Fig. 6B). Signiﬁcantly increasing higher cellFig. 6. (A) Overview of the quantiﬁcation of matrix, axonal outgrowth, activated and apop
photomicrographs taken at þ3 mmwithin the matrix in sections incubated with a-cleaved ca
cells; double staining, right panel).numbers were detected in the formed matrix with increasing de-
gree of acetylation of the tubes; i.e. with a low number in DAI tubes.
There were extensive numbers of cleaved caspase 3 stained
Schwann cells in the distal nerve segment, but with no difference
between the tubes of different DAs.
3.2.2.5. Total number of DAPI-stained cells. DAPI-stained cells were
present in the matrix of all tubes, but with no difference among the
DAs. However, there was a signiﬁcant difference in DAPI-stained
cells in the distal nerve segment (Table 1).
3.2.2.6. Correlations. The thickness of the formedmatrix correlated
strongly with the length of the axonal outgrowth (rho-value up to
0.9; p-value < 0.02; Spearman), particularly in the DAI- (w2%) and
DAIII- (w20%) tubes. The length of axonal outgrowth did only
correlate with the number of cleaved caspase 3 stained Schwann
cells in the distal nerve segment (rho 0.44, p ¼ 0.016).
In the distal nerve segment, the number of cleaved caspase 3
stained Schwann cells negatively correlated (rho 0.53, p ¼ 0.003)
with the total number of DAPI stained cells, particularly in DAIII-
tubes. No other relevant correlations were observed.
3.2.3. Long term observation (13 weeks) regeneration
3.2.3.1. Functional recovery. Long term regeneration was evaluated
with regard to functional recovery analysing the SSI and non-
invasive and invasive electrophysiology after different time pointstotic Schwann cells and total number of cells (DAPI) in the model. (B) Representative
spase 3 antibody (green, apoptotic cells; left panel) and a-S100 antibody (red, Schwann
Table 1
Dimensions, length of axonal outgrowth, and numbers of activated and apoptotic Schwann cells and total number of DAPI stained cells in the matrix and in the distal nerve
segments in rat sciatic nerve defects bridged by differentially acetylated chitosan tubes (DAI ¼ w2%; DAII ¼w5%; DAIII ¼w20%).
DAI (n ¼ 10) DAII (n ¼ 10) DAIII (n ¼ 9) p-Values
Matrix diameter at 0 mm (mm) 317 [303e339] 313 [303e334] 303 [292e321] 0.36
Matrix diameter at 3 mm (mm) 242 [222e302] 250 [236e287] 232 [224e245] 0.29
Matrix diameter at 5 mm (mm) 242 [232e278] 248 [232e280] 237 [228e244] 0.54
Axonal outgrowth (mm) 8.61 [7.51e9.01] 8.64 [8.04e9.31] 7.91 [7.43e8.76] 0.28
ATF3 stained cells in the matrix (at 3 mm) (% of total) 0.4 [0e0.7] 0.4 [0e0.7] 0.3 [0e0.3] 0.39
ATF 3 stained cells in the distal nerve segment (% of total) 19.8 [18.6e21.6]c 25.2 [20.2e28.3]b 30.6 [27.9e35.3] 0.0001
Cleaved caspase 3 stained cells in the matrix (at 3 mm) (% of total) 4.7 [2.7e7.6]a 15.3 [5.8e19.5]b 20.5 [18.0e23.0] 0.0001
Cleaved caspase 3 stained cells in the distal nerve segment (% of total) 22.1 [20.5e28.3] 27.7 [22.9e34.9] 21.5 [20.4e22.9] 0.07
Total number of DAPI stained cells in the matrix (no/mm2) 1010 [966e1046] 1057 [981e1080] 1011 [833e1030] 0.18
Total number of DAPI stained cells in the distal nerve segment (no/mm2) 981 [914e1022]a 888 [866e919]b 1094 [1059e1142] 0.0001
Values are median [25the75th percentiles]. p-Values based on KruskaleWallis-test.
Bold writing indicates statistical signiﬁcance.
a Different from medium and high acetylation.
b Different from high acetylation.
c Different from high acetylation (ManneWhitney-test).
K. Haastert-Talini et al. / Biomaterials 34 (2013) 9886e99049896(Fig.1). Eventual changes from initial numbers of animals per group
are indicated throughout and due to hamstring toe contractures or
signs of autotomy, which excluded animals from certain tests at a
certain time point. Additionally, few animals died over the long
term observation period because of low tolerance to the repeated
anaesthesia. Actual animal numbers are appropriately indicated in
the graphs below.
3.2.3.2. Static sciatic index (SSI). With regard to the SSI a signiﬁcant
decrease from pre to post nerve defect and reconstruction was
found which remained signiﬁcantly decreased till the end of the
observation period. Interestingly, the post-surgery performances of
the different experimental groups revealed no signiﬁcant differ-
ences, also when comparing the reconstruction of the nerve with
hollow chitosan tubes to the autologous nerve graft (Fig. 7A). This
suggests that the hollow chitosan tubes, independently of their DA,
inﬂuence motor regeneration in the same extent as the gold
standard.
3.2.3.3. Electrophysiological assessment. Compound muscle action
potentials (CMAPs) were serially recorded from the tibialis anterior
muscle (TA) and plantar muscles (PL) at 4, 9, and 12 weeks after
nerve reconstruction. Additionally, a ﬁnal invasive recording was
performed on the last day of observation in week 13. Four weeks
after nerve reconstruction no CMAPs were evocable for both loca-
tions. However, nine weeks after nerve reconstruction 62% of the
animals treated with autologous nerve grafts demonstrated evoked
CMAPs in the TA, while signiﬁcantly less animals of the other
groups showed these signs of reinnervation (6e29%, Table 2).
Twelve weeks after nerve reconstruction the number of chitosan
tubes treated animals with evoked CMAPs recordable from the TA
muscle reached a level comparable to the autologous nerve grafted
animals. When recordings were performed from the PL muscles, a
similar development of motor recovery was detectable (Table 2).
These data reveal that chitosan tubes of all degrees of acetylation
allow functional recovery, which almost reaches the same distri-
bution as after autologous nerve grafting.
Furthermore, the CMAPs were analysed in more detail, as was
the nerve conduction velocity (NCV). No signiﬁcant differences
among the amplitudes of evocable CMAPs could be detected among
the groups during the non-invasive and invasive measurements
(data not shown). Also for the NCV-ratio (ipsilateral/contralateral),
the TA and the PL muscles data revealed no signiﬁcant differences
in comparison with autologous nerve grafting and bridging of the
nerve defects with chitosan hollow tubes or among the chitosan
tubes with different degrees of acetylation (Fig. 7B).3.2.3.4. Muscle weight ratio. After the ﬁnal electrophysiological
measurements, the muscle weight ratios (gipsi/gcontra) of the lower
limb muscles were determined after harvest of the tibialis anterior
and gastrocnemius muscles (Fig. 1) and revealed no differences
among the experimental groups (Fig. 7C).
3.2.4. Histomorphological evaluation
3.2.4.1. Distal nerve stereology. The results of the stereological
assessment of myelinated ﬁbre number and axon diameter, ﬁbre
diameter, myelin thickness and g-ratio of all experimental groups
are shown in Fig. 8. The total numbers of myelinated ﬁbres (Fig. 8A)
are signiﬁcantly different in all groups towards the healthy nerve
(*p  0.05; **p  0.01), but only the nerve distal to DAI-chitosan
tubes is signiﬁcantly different compared to the autologous nerve
graft group (#p  0.05). With regard to axon and ﬁbre diameters
and myelin thickness (Fig. 8B), all the experimental groups differ
from healthy nerves (**p 0.01) but no differences are seen among
them. In Fig. 9 high-resolution representative images of semithin
sections of regenerated sciatic nerves are shown in comparison to
the contralateral healthy control (Fig. 9A: healthy contralateral
nerve; Fig. 9B: autologous nerve graft; Fig. 9C: DAI; Fig. 9D: DAII;
Fig. 9E: DAIII). Nerve ﬁbre size distribution is also reported (Fig. 9Fe
J). The distribution is signiﬁcantly different between healthy and
regenerated nerves but again no signiﬁcant differences in ﬁbre size
distribution could be detected among the experimental groups.
3.2.4.2. Immunological nerve tissue reaction. In addition to the
stereology, the area around the distal suture (bridging 1 mm dis-
tance, see Fig. 1) was evaluated with regard to the presence of
activated macrophages in the regenerated nerve tissue after
double-staining for the ED1-antigen and NF200-Neuroﬁlaments
(Fig. 10AeC). Whereas in nerves regenerated through DAI and
DAII chitosan tubes similar amounts of ED1-immunopositive cells
were found, nerves regenerated through DAIII chitosan tubes
contained signiﬁcantly higher numbers of these cells, i.e. activated
macrophages. As expected, in all tubes the number of macrophages
was signiﬁcantly lower than in autologous nerve grafts where it can
be attributed to myelin debris removal (Fig. 10D). On the same
sections of the regenerated nerves the thickness of the perineurium
was measured. Interestingly, whereas thickness of the perineurium
of nerves regenerated through DAI and DAII chitosan tubes was
comparable with the perineurium thickness in the autologous
nerve graft group, nerves regenerated through DAIII chitosan tubes
displayed a signiﬁcantly thicker perineurium (Fig. 10E). The higher
number of macrophages together with a thicker perineurium point
to an immunological reaction in DAIII.
Fig. 7. Functional evaluation of motor recovery revealed no signiﬁcant differences among the gold standard autologous nerve graft and the nerve reconstructionwith chitosan tubes
of different degree of acetylation. DAI ¼ w2%; DAII ¼ w5%; DAIII ¼ w20%. (A) Results of the calculation of the static sciatic index (SSI). Statistical test: two way ANOVA, Tukey’s
multiple comparison, triple asterix indicating difference to post nerve lesion values, p < 0.001. (B) Calculation of the nerve conduction velocity ratio. (C) Calculation of the lower
limb muscle weight ratio.
K. Haastert-Talini et al. / Biomaterials 34 (2013) 9886e9904 98973.2.4.3. Connective tissue evaluation. There was never a strong scar
tissue formation around the chitosan tubes. Similar as performed
18 days after nerve reconstruction (Fig. 1), the connective tissue
surrounding the tubes was explanted and analysed morphologi-
cally with regard to its optical density, its area and thickness, thepresence of multinucleated giant cells (HE staining, Fig. 2B), and
immunohistochemically for the presence of activated macrophages
(ED1-immunopositive cells). Similar to the ﬁndings after short term
nerve reconstruction, the optical density of the connective tissue
surrounding DAIII chitosan tubes was signiﬁcantly increased in
Table 2
Increasing distribution of animals per group which showed evocable compound muscle action potentials in the tibialis anterior or plantar muscles during the regeneration
period after autologous nerve grafting or nerve reconstruction with chitosan tubes of different degree of acetylation (DAI ¼w2%; DAII ¼w5%; DAIII ¼w20%).
9 weeks 12 weeks 13 weeks (invasive)
Animals/group Percentage Signiﬁcant
difference
Animals/group Percentage Signiﬁcant
difference
Animals/group Percentage Signiﬁcant
difference
Tibialis anterior muscle
Autologous nerve graft 8/13 62% 13/13 100% 13/13 100%
DAI 1/17 6% # 14/16 88% #z 16/16 100% z
DAII 2/16 13% # 11/16 69% #y 13/14 93% #y
DAIII 5/17 29% #yz 13/16 82% #y 12/15 80% #yz
Plantar muscles
Autologous nerve graft 8/10 80% 10/10 100% 10/10 100%
DAI 5/10 50% # 8/10 80% #z 9/10 90% #z
DAII 6/12 50% # 7/11 64% #y 7/10 70% #y
DAIII 4/12 33% #y 7/11 64% #z 6/9 67% #yz
Signiﬁcant differences p < 0.05 are indicated as follows: # versus nerve autograft, y versus DAI-chitosan tube, z versus DAII-chitosan tube.
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(Fig. 5A). Connective tissue area and thickness displayed no sig-
niﬁcant differences among chitosan tubes of different DAs after 3
months and, in addition, no signiﬁcant differences were obvious
when compared with the data after 18 days (Fig. 5B). Multinucle-
ated giant cells were only detected in two animals (DAI group)
displaying a signiﬁcant reduction of the foreign body reaction at 3
months after nerve reconstruction (Fig. 5C). Quantiﬁcation of ED1-
immunopositive cells revealed a highly signiﬁcant reduction of
their appearance as compared to the evaluation after short term
nerve reconstruction (18 days, Fig. 5D). However, at both time
points no differences in the immunological connective tissue re-
action to chitosan tubes of different degrees of acetylation were
obvious.
3.2.5. Assessment of chitosan tube properties after explantation
In addition to the above mentioned analyses of the connective
tissue and regenerated nerve tissue peculiarities, the chitosan tubes
were also macroscopically analysed upon explantation. The prop-
erties of the tubes differed substantially among the different de-
grees of acetylation. While 5 days after nerve reconstruction no
macroscopic differences were detectable, DAIII-chitosan tubes
showed signs of beginning degradation already 18 days after nerve
reconstruction. In two of six DAIII-tubes small longitudinal ﬁssures
were visible through the surgery microscope and a 3rd sample
displayed a rough surface. The degradation of DAIII-chitosan tubes
was much further in progress three months after nerve recon-
structionwhen these tubes displayed longitudinal ﬁssures (4 out of
15), a fragmentary appearance that broke apart upon nerve tissue
harvest (8/15) or they were already longitudinally broken and
compressed (3/15). The crack-lines and sharp edged pieces
appearing with progressed degeneration could have potentially
damaged already regenerated nerve tissue. In contrast, DAI- andTable 3
Results of the mechanical and biochemical analyses of chitosan tubes, which were
explanted 13 weeks after nerve reconstruction. The degree of acetylation was
determined in NMR spectrometry and the molecular weight (MW) was determined
using the GPC method. With the latter no clear differences have been detected
among the chitosan tubes of different DA. The symbols shown in the respective
column show a tendency to most obvious reduction of MW in DAI chitosan tubes.
Chitosan
tubes
Before
implantation
DA
13 weeks after nerve reconstruction
DA Solubility Toughness MW
degradation
DAI w2% 1.1%  0.3% e e þþ þþþ
DAII w5% 3.6%  0.3% e þ þþ
DAIII w20% 14.6%  1.1% þþ e e (brittle) þDAII-chitosan tubes mostly displayed a regular shape and ﬁrmness
(13/16 and 11/15, respectively) and rarely a slightly bent shape (3
each) or a slight compression (DAII only: 1/15), both together with
regular ﬁrmness. The colour of DAI and DAII tubes was changed to a
serous yellow, while in DAIII tubes the change of colour was min-
imal. Fig.11 shows representative samples of all chitosan tube types
before and after nerve reconstruction. A cracked DAIII-chitosan
tube 13 weeks after nerve reconstruction is shown in Fig. 12,
demonstrating that degeneration of the tubes leads to damages
that are already microscopically evident and can easily be
conﬁrmed in ultrastructural images.
3.2.5.1. Biochemical characterization (Table 3). The GPC chromato-
graphs obtained showed an increase in the retention time for all
chitosan tubes (themolecular weight distribution has shifted to the
right) independently of the DA of the raw material. This evidence
highlights the fact that all chitosan tubes used to bridge the nerve
defects suffer depolymerisation during the time in vivo after nerve
reconstruction. The DAIII-tubes showed a more symmetrical mo-
lecular weight (MW) degradation when compared with the other
chitosan tubes with less DA. Nevertheless all samples analysed
from the same group of chitosan tubes (DAI, DAII or DAIII) showed a
similar chromatographic proﬁle among them. This demonstrates a
rather high reproducibility of the MW of the biopolymer (dis-
persibility of molecular weights) within the sample tubes, which
suggests that both the tube production and biological activity are
similar for each group. Homogeneity of the results within the three
groups DAIeDAIII was quite high.
The variation of the DA among the chitosan tubes prior to nerve
reconstruction and after explantation at 3 months was also inves-
tigated. Upon analytical evaluation of the NMR spectra, all sample
chitosan tubes showed a rather similar DA before and after nerve
reconstruction, demonstrating that there is no visible hydrolysis of
the remaining acetyl groups of the chitosan main chain by bio-
logical action. Regarding solubility there was a clear tendency of
chitosan tubes with higher DA to show a higher solubility when
compared with other chitosan tubes of lower DA. In the case of DAI-
chitosan tubes (DA w2%) it was necessary to heat the solution in
order to achieve a total dissolution of the tubes. On the other hand,
the toughness of the tubes after explantation at 3 months was
higher in DAI and DAII chitosan tubes when compared to DAIII-
tubes, which were brittle.4. Discussion
During the last years there has been an interest in chitosan as a
suitable biomaterial for medical and pharmaceutical applications
Fig. 8. The distal nerve (5 mm segment harvested 1 mm distal to the distal suture) was stereologically analysed in order to assess the myelinated ﬁbres. (A) Result of myelinated
ﬁbre quantiﬁcation. (B) Results of ﬁbre size parameter analyses. Samples of healthy contralateral nerves were compared to nerve samples regenerated through autologous nerve
grafts or chitosan tubes of different degrees of acetylation (DAI ¼w2%; DAII ¼w5%; DAIII ¼w20%). *p  0.05 and **p  0.01: experimental groups vs healthy nerve; #p  0.05: DAI
vs autologous nerve graft.
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These properties qualiﬁed chitosan also as a putative candidate
material for fabrication of peripheral nerve reconstruction devices
[18,32]. However, the poor mechanical strength of chitosan con-
duits, along with pre-mature degradation and loss of structural
integrity in vivo, were major limitations which prevented their
commercial application in neural tissue engineering until now
[15,18,32]. The present study, using chitosan conduits with
different degrees of acetylation, indicates that ﬁne-tuned chitosan
tubes induce sufﬁcient peripheral nerve regenerationwhen used to
reconstruct a 10 mm nerve defect in adult rat sciatic nerves.
In vitro cytotoxicity tests with extracts from the different chi-
tosan tubes revealed no detrimental effects on cell metabolic
viability. Indeed when observing Fig. 3, it is noticeable that thevalues obtained are even above those obtained with the positive
control extracts. As it is known chitosan withholds several struc-
tural afﬁnities with animal/human tissues [33], however, when it
degrades it can induce an increase of cell metabolic viability.
Moreover, this is probably the reason why DAIII extracts disclose
higher metabolic viabilities when compared to DAI or DAII extracts.
Short and long term in vivo studies demonstrated that i) mainly
DAII chitosan tubes support nerve regeneration in a similar extent
as the gold standard autologous nerve graft with regard to both
function and morphology, while DAI and DAIII chitosan tubes
demonstrated some shortcomings ii) the lesion-induced regulation
of regeneration associated neurotrophic factors in the corre-
sponding dorsal root ganglia and the secretion of BDNF and NGF
into the chitosan tubes was not altered due to their different DAs,
Fig. 9. High resolution images of representative semithin sections, stained with Toluidine blue, of nerve samples (A) from a healthy contralateral nerve, (B) regenerated through an
autologous nerve graft, (C)e(E) regenerated through chitosan tubes (DAI ¼w2%; DAII ¼w5%; DAIII ¼w20%). Scale bars: 20 mm. (F)e(J) ﬁbre size distribution in the analysed groups
of nerve samples.
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Fig. 10. (A)e(C) Representative photomicrographs of a cross-section of nerve tissue regenerated through DAIII-chitosan tubes analysed for the number of activated macrophages
(ED-1-immunopositive cells), Scale bars: 100 mm. (D) Results of ED-1-cell quantiﬁcation. Signiﬁcantly less immunological tissue reaction was seen in nerves regenerated through
DAI- or DAII-chitosan tubes compared to DAIII-group samples. (E) Measurement of the thickness of the perineurium in the regenerated nerve tissue further revealed that
signiﬁcantly more connective nerve tissue was formed inside of DAIII-chitosan tubes when compared to DAI- and DAII-tubes. DAI ¼ w2%; DAII ¼ w5%; DAIII ¼ w20%. Statistical
tests used: (D) KruskaleWallis Test, Dunn’s multiple comparison, asterix indicating inter-group differences to autologous nerve graft and solid rhombus indicating inter-group
difference to DAIII-chitosan tubes p < 0.05; (E) One way ANOVA, Bonferroni multiple comparisons test, asterix indicating difference to DAIII-chitosan tubes, p < 0.001.
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contained a lower number of cleaved caspase 3 stained, i.e.
apoptotic, Schwann cells, as compared to DAIII chitosan tubes, iv)
the number of ED1-immunopositive cells, i.e. activated macro-
phages, and thus the tissue reaction, in the regenerated nerve was
signiﬁcantly lower after nerve reconstruction with DAI and DAII
chitosan tubes, and v) the material-induced immunoreaction in the
connective tissue formed around the chitosan tubes was not altered
by their different DA (equal numbers of multinucleated giant cells
and activated macrophages) and was considerably reduced from 18
days to 3 months after nerve reconstruction.
Although the chitosan tubes with the different DAs allowed
good structural and functional sciatic nerve regeneration, there
were obvious differences with regard to the speed of their degra-
dation (structural integrity), which were most evident at 3 months
after nerve reconstruction. Overall, the DAIII chitosan tubes were
much less stable during the observation period, which is probably
the reason for the development of connective tissue with a signif-
icantly higher optical density. After explantation, tubes of the
different DAs revealed differences with regard to consistency and
chemical properties, which were related to the different grades of
degradation. Macroscopically detectable crack lines were also
obvious in SEM ultrastructures, although the electron microscopic
appearance was rather similar among the three groups. However,
the DAI chitosan tubes display almost no degradability.
Regarding previous chitosan devices, the main differences to the
chitosan tubes presented here include their ﬁne-tuned chemical
structure which provided an optimal substrate for the formation of
a regenerative matrix, where the thickness of such matrix corre-
lated to the length of the outgrowing axons in accordance with
ﬁndings from silicone tubes [34]. This goes along with the high
mechanical compression strength and collapse stability. Further-
more, these chitosan tubes are completely transparent to ease thesurgical procedure, and because also microneedles go through the
material very easily, they seemed to be very suitable for bridging
nerve defects. Moreover, the chitosan raw material and the tubes
are manufactured according to ISO standard protocols for medical
devices, which is a pre-requisite for regulatory approval and com-
mercial application.
Analysis of the early regeneration phase (21 days) after nerve
reconstruction with the chitosan tubes of different DAs demon-
strated a higher number of activated Schwann cells in the distal
segments of nerves regenerated through DAIII tubes. This may
mirror that Schwann cells are stimulated and prepared to attract
the outgrowing axons [26,27]. However, there was a tendency to
shorter axonal outgrowth in this early regeneration phase in the
same group of animals. In addition, the number of cells stained for
cleaved caspase 3 was signiﬁcantly higher in the regenerative
matrix within DAIII chitosan tubes. The latter may be detrimental
for axonal outgrowth although the number of such cells did not
correlate with axonal outgrowth.
While usually not considered in studies where new materials
are analysed, it is worth to consider other endogenous early events
of regeneration in addition to the immunological reaction and the
regenerative efﬁciency in the presence of the foreign material.
During regeneration a distinct pattern of neurotrophic factors is
produced and secreted by the nerve ends [35]. Pooled tube contents
were collected at 5 and 18 days after nerve reconstruction and
Western Blots were performed for BDNF and NGF, which revealed
no differences among the different experimental groups. Moreover,
the analysis of the corresponding dorsal root ganglia for expression
of different growth factors, which are regulated during the regen-
eration process, did also not reveal differences among the different
experimental groups. This suggests that the presence of the chi-
tosan tubes, irrespective of their DAs, does not disturb these mo-
lecular processes.
Fig. 11. Left column: representative SEM images of chitosan tubes of different degree of acetylation before nerve reconstruction. Right column: representative SEM images of
example chitosan tubes explanted and analysed 13 weeks after nerve reconstruction. DAI ¼ w2%; DAII ¼ w5%; DAIII ¼ w20%.
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graft is the gold standard to overcome substance loss after pe-
ripheral nerve injury [1]. Thus, any nerve conduits have to be
compared with this standard. With regard to the stereologicalFig. 12. (A) Chitosan tube of DAIII (w20% acetylation) upon explantation 13 weeks after ne
connective tissue is opaque and the tube contains regenerated nerve tissue. (B) SEM imag
roughened outer surface of the tube after long term in vivo.parameters of the regeneration efﬁciency, the chitosan tubes pre-
sented in this study supported axonal regrowth to a similar extent
as the autologous nerve graft. However, nerves regenerated
through DAI chitosan tubes revealed a signiﬁcantly higher totalrve reconstruction, displaying several longitudinal ﬁssures and a clear crack line. The
e displaying the ultrastructure of the DAIII chitosan tube shown in (A) as well as the
K. Haastert-Talini et al. / Biomaterials 34 (2013) 9886e9904 9903number of myelinated axons as compared to the gold standard. The
increased number of regenerated axons after 3 months can be the
morphological correlate of enhanced sprouting in the presence of
DAI chitosan tubes, although ﬁbre size under all experimental
conditions was not different. Enhanced sprouting could eventually
become a limiting factor for the outcome of functional recovery
[36] and thus argues against the use of DAI chitosan tubes for future
trials.
The good morphological regeneration in the presence of chito-
san tubes is also reﬂected in the behavioural and functional pa-
rameters analysed. Regarding the SSI, animals of the different
experimental groups displayed no signiﬁcant differences compared
to the gold standard. Moreover, although the electrophysiological
measurements revealed a faster functional recovery in animals
treated with autologous nerve grafts, after 3 months there were no
signiﬁcant differences with regard to the functional data among all
experimental groups detectable. Interestingly, we found morpho-
logical differences with regard to non-neuronal tissue in the re-
generated nerves, which have important impact on the selection of
the type of chitosan tube for future applications. Threemonths after
nerve reconstruction, the highest number of activated macro-
phages was present in nerves regenerated through autologous
nerve grafts, which is due to the need for myelin debris removal in
the autografts [35]. However, it is noteworthy that the number of
activated macrophages within the regenerated nerves was signiﬁ-
cantly increased in the DAIII samples when compared to DAI and
DAII samples. In addition, the thickness of the perineurium was
signiﬁcantly higher in nerves regenerated through DAIII chitosan
tubes compared to DAI and DAII tubes and the autologous nerve
graft. Both facts could reﬂect the acute tissue reaction to the faster
degrading DAIII chitosan tubes, which argues against the use of
those tubes for future trials.
Regarding the connective tissue surrounding the tube, no sig-
niﬁcant differences in thickness, area, numbers of multinucleated
giant cells, and activated macrophages among the three DA groups
were obvious. However, we detected a shift to a higher optical
density of the unfolded connective tissue formed around DAIII
chitosan tubes. Previously, it was reported that subcutaneously
implanted chitosan scaffolds of different DAs induced different
inﬂammatory responses which were more intense in the presence
of materials with a DA of 15% as compared to materials with a DA of
4% [37]. In another study, chitosan membranes with different DAs
were implanted under the calvarial periosteum and revealed as
well different inﬂammation reactions [38]. Furthermore, chitosan
sheets of different acetylation grades implanted into the spinal cord
elicited different morphological reactions also in the nervous tissue
[39]. In addition to different modes of fabrication of the chitosan
devices, also the investigated implantation sites were different and
could be the reason why in the present study varying reactions of
the tube-surrounding connective tissue to the different DAs were
minimized. Moreover, after 3 months only 1e2 remaining giant
cells were found in the connective tissue preparations, which is the
pattern of a reduced tissue response even seen at one year after the
use of silicone tubes in nerve repair in humans, thus, the chitosan
tubes can be judged as immunologically inert [5,40].
5. Conclusions
This comprehensive study provides a complex view on the
suitability of ﬁne-tuned chitosan tubes of different degree of
acetylation to support peripheral nerve regeneration. With regard
to the morphological and functional parameters of nerve regener-
ation, the chitosan tubes displayed a similar efﬁciency as the gold
standard. However, differences were discovered regarding the
immunological reaction, as well as other cellular processes, in theregenerative matrix and distal to the regenerated nerve and the
chemical properties of tubes with the different DAs. While DAIII
chitosan tubes (DA: w20%) displayed a too fast degradation and
induced degradation related tissue reactions, DAI tubes (DA:w2%)
induced an unintended sprouting effect in regenerating nerve ﬁ-
bres. Our ﬁndings point to DAII chitosan tubes (DA: w5%) as the
most supporting ones for peripheral nerve regeneration and as the
ﬁrst choice for ongoing applications in nerve reconstruction.
Acknowledgements
This work has received funding from the European Community’s
Seventh Framework Programme (FP7-HEALTH-2011) under grant
agreement n 278612 (BIOHYBRID).
We gratefully acknowledge the excellent technical assistance
from the following people: members of the Institute of Neuro-
anatomy (Hannover Medical School): S. Fischer, N. Heidrich, K.
Kuhlemann, J. Metzen and H. Streich; members of Università di
Torino: S. Bompasso; and the guest researcher at Department of
Clinical Sciences e Hand Surgery, Lund University, Dr A. Kodama
from Hiroshima University, Hiroshima, Japan.
References
[1] Deumens R, Bozkurt A,MeekMF,MarcusMA, Joosten EA,Weis J, et al. Repairing
injured peripheral nerves: bridging the gap. Prog Neurobiol 2010;92:245e76.
[2] Ray WZ, Mackinnon SE. Management of nerve gaps: autografts, allografts,
nerve transfers, and end-to-side neurorrhaphy. Exp Neurol 2010;223:77e85.
[3] Battiston B, Raimondo S, Tos P, Gaidano V, Audisio C, Scevola A, et al. Chapter 11:
tissue engineering of peripheral nerves. Int Rev Neurobiol 2009;87:227e49.
[4] Xu H, Yan Y, Li S. PDLLA/chondroitin sulfate/chitosan/NGF conduits for pe-
ripheral nerve regeneration. Biomaterials 2011;32:4506e16.
[5] Dahlin LB, Anagnostaki L, Lundborg G. Tissue response to silicone tubes used
to repair human median and ulnar nerves. Scand J Plast Reconstr Surg Hand
Surg 2001;35:29e34.
[6] Lundborg G, Rosen B, Dahlin L, Holmberg J, Rosen I. Tubular repair of the
median or ulnar nerve in the human forearm: a 5-year follow-up. J Hand Surg
Br 2004;29:100e7.
[7] Weber RA, Breidenbach WC, Brown RE, Jabaley ME, Mass DP. A randomized
prospective study of polyglycolic acid conduits for digital nerve reconstruction
in humans. Plast Reconstr Surg 2000;106:1036e45 discussion 46e8.
[8] Archibald SJ, Krarup C, Shefner J, Li ST, Madison RD. A collagen-based nerve
guide conduit for peripheral nerve repair: an electrophysiological study of
nerve regeneration in rodents and nonhuman primates. J Comp Neurol
1991;306:685e96.
[9] Archibald SJ, Shefner J, Krarup C, Madison RD. Monkey median nerve repaired
by nerve graft or collagen nerve guide tube. J Neurosci 1995;15:4109e23.
[10] Bertleff MJ, Meek MF, Nicolai JP. A prospective clinical evaluation of biode-
gradable neurolac nerve guides for sensory nerve repair in the hand. J Hand
Surg Am 2005;30:513e8.
[11] Hernandez-Cortes P, Garrido J, Camara M, Ravassa FO. Failed digital nerve
reconstruction by foreign body reaction to Neurolac nerve conduit. Micro-
surgery 2010;30:414e6.
[12] Yuan Y, Zhang P, Yang Y, Wang X, Gu X. The interaction of Schwann cells with
chitosan membranes and ﬁbers in vitro. Biomaterials 2004;25:4273e8.
[13] Jiang X, Lim SH, Mao HQ, Chew SY. Current applications and future perspec-
tives of artiﬁcial nerve conduits. Exp Neurol 2010;223:86e101.
[14] Dahlin LB, Lundborg G. Use of tubes in peripheral nerve repair. Neurosurg Clin
N Am 2001;12:341e52.
[15] Freier T, Koh HS, Kazazian K, Shoichet MS. Controlling cell adhesion and
degradation of chitosan ﬁlms by N-acetylation. Biomaterials 2005;26:5872e8.
[16] Simoes MJ, Gartner A, Shirosaki Y, Gil da Costa RM, Cortez PP, Gartner F, et al.
In vitro and in vivo chitosan membranes testing for peripheral nerve recon-
struction. Acta Med Port 2011;24:43e52.
[17] AoQ, FungCK, TsuiAY, Cai S, ZuoHC, ChanYS, et al. The regenerationof transected
sciatic nerves of adult rats using chitosan nerve conduits seeded with bone
marrow stromal cell-derived Schwann cells. Biomaterials 2011;32:787e96.
[18] Freier T, Montenegro R, Shan Koh H, Shoichet MS. Chitin-based tubes for
tissue engineering in the nervous system. Biomaterials 2005;26:4624e32.
[19] Hirai A, Odani H, Nakajima A. Determination of degree of deacetylation of
chitosan by 1H NMR spectroscopy. Polym Bull 1991;26:87e94.
[20] Salgado AJ, Coutinho OP, Reis RL. Novel starch-based scaffolds for bone tissue
engineering: cytotoxicity, cell culture, and protein expression. Tissue Eng
2004;10:465e74.
[21] Salgado AJ, Gomes ME, Coutinho OP, Reis RL. Isolation and osteogenic dif-
ferentiation of bone-marrow progenitor cells for application in tissue engi-
neering. Methods Mol Biol 2004;238:123e30.
K. Haastert-Talini et al. / Biomaterials 34 (2013) 9886e99049904[22] Haastert-Talini K, Schmitte R, Korte N, Klode D, Ratzka A, Grothe C. Electrical
stimulation accelerates axonal and functional peripheral nerve regeneration
across long gaps. J Neurotrauma 2011;28:661e74.
[23] Cobianchi S, Casals-Diaz L, Jaramillo J, Navarro X. Differential effects of activity
dependent treatments on axonal regeneration and neuropathic pain after
peripheral nerve injury. Exp Neurol 2013;240:157e67.
[24] Rumpel R, Alam M, Klein A, Özer M, Wesemann M, Jin X, et al. Neuronal ﬁring
activity and gene expression changes in the subthalamic nucleus after
transplantation of dopamine neurons in hemiparkinsonian rats. Neurobiol Dis
2013;59:230e43.
[25] Ratzka A, Kalve I, Ozer M, Nobre A, Wesemann M, Jungnickel J, et al. The co-
layer method as an efﬁcient way to genetically modify mesencephalic pro-
genitor cells transplanted into 6-OHDA rat model of Parkinson’s disease. Cell
Transplant 2012;21:749e62.
[26] Saito H, Dahlin LB. Expression of ATF3 and axonal outgrowth are impaired
after delayed nerve repair. BMC Neurosci 2008;9:88.
[27] Tsuda Y, Kanje M, Dahlin LB. Axonal outgrowth is associated with increased
ERK 1/2 activation but decreased caspase 3 linked cell death in Schwann cells
after immediate nerve repair in rats. BMC Neurosci 2011;12:12.
[28] Stenberg L, Kanje M, Dolezal K, Dahlin LB. Expression of activating tran-
scription factor 3 (ATF 3) and caspase 3 in Schwann cells and axonal
outgrowth after sciatic nerve repair in diabetic BB rats. Neurosci Lett
2012;515:34e8.
[29] Huelsenbeck SC, Rohrbeck A, Handreck A, Hellmich G, Kiaei E, Roettinger I,
et al. C3 peptide promotes axonal regeneration and functional motor recovery
after peripheral nerve injury. Neurotherapeutics 2012;9:185e98.
[30] Raimondo S, Fornaro M, Di Scipio F, Ronchi G, Giacobini-Robecchi MG,
Geuna S. Chapter 5: methods and protocols in peripheral nerve regeneration
experimental research: part II e morphological techniques. Int Rev Neurobiol
2009;87:81e103.[31] Geuna S. Appreciating the difference between design-based and model-based
sampling strategies in quantitative morphology of the nervous system. J Comp
Neurol 2000;427:333e9.
[32] Yamaguchi I, Itoh S, Suzuki M, Osaka A, Tanaka J. The chitosan prepared from
crab tendons: II. The chitosan/apatite composites and their application to
nerve regeneration. Biomaterials 2003;24:3285e92.
[33] Costa-Pinto AR, Salgado AJ, Correlo VM, Sol P, Bhattacharya M, Charbord P,
et al. Adhesion, proliferation, and osteogenic differentiation of a mouse
mesenchymal stem cell line (BMC9) seeded on novel melt-based chitosan/
polyester 3D porous scaffolds. Tissue Eng Part A 2008;14:1049e57.
[34] Zhao Q, Lundborg G, Danielsen N, Bjursten LM, Dahlin LB. Nerve regener-
ation in a ‘pseudo-nerve’ graft created in a silicone tube. Brain Res
1997;769:125e34.
[35] Schmidt CE, Leach JB. Neural tissue engineering: strategies for repair and
regeneration. Annu Rev Biomed Eng 2003;5:293e347.
[36] Streppel M, Azzolin N, Dohm S, Guntinas-Lichius O, Haas C, Grothe C, et al.
Focal application of neutralizing antibodies to soluble neurotrophic factors
reduces collateral axonal branching after peripheral nerve lesion. Eur J Neu-
rosci 2002;15:1327e42.
[37] Barbosa JN, Amaral IF, Aguas AP, Barbosa MA. Evaluation of the effect of the
degree of acetylation on the inﬂammatory response to 3D porous chitosan
scaffolds. J Biomed Mater Res A 2010;93:20e8.
[38] Hidaka Y, Ito M, Mori K, Yagasaki H, Kafrawy AH. Histopathological and
immunohistochemical studies of membranes of deacetylated chitin de-
rivatives implanted over rat calvaria. J Biomed Mater Res 1999;46:418e23.
[39] Yussof SJM, Halim AS, Saad AZM, Jaafar H. Evaluation of the biocompatibility
of a bilayer chitosan skin regenerating template, human skin allograft, and
integra implants in rats. ISRN Mater Sci 2011;2011:7.
[40] Brodbeck WG, Anderson JM. Giant cell formation and function. Curr Opin
Hematol 2009;16:53e7.
